Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zepp Health (ZEPP) Accumulated Expenses (2016 - 2024)

Historic Accumulated Expenses for Zepp Health (ZEPP) over the last 9 years, with Q4 2024 value amounting to $37.6 million.

  • Zepp Health's Accumulated Expenses fell 1427.22% to $37.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $37.6 million, marking a year-over-year decrease of 1427.22%. This contributed to the annual value of $37.6 million for FY2024, which is 1546.46% down from last year.
  • Latest data reveals that Zepp Health reported Accumulated Expenses of $37.6 million as of Q4 2024, which was down 1427.22% from $43.8 million recorded in Q4 2023.
  • Zepp Health's Accumulated Expenses' 5-year high stood at $49.4 million during Q4 2021, with a 5-year trough of $27.8 million in Q4 2022.
  • For the 5-year period, Zepp Health's Accumulated Expenses averaged around $39.3 million, with its median value being $38.1 million (2020).
  • Per our database at Business Quant, Zepp Health's Accumulated Expenses crashed by 4373.98% in 2022 and then skyrocketed by 5758.79% in 2023.
  • Quarter analysis of 5 years shows Zepp Health's Accumulated Expenses stood at $38.1 million in 2020, then rose by 29.87% to $49.4 million in 2021, then crashed by 43.74% to $27.8 million in 2022, then soared by 57.59% to $43.8 million in 2023, then decreased by 14.27% to $37.6 million in 2024.
  • Its last three reported values are $37.6 million in Q4 2024, $43.8 million for Q4 2023, and $27.8 million during Q4 2022.